Medical/Pharmaceuticals
Menarini Silicon Biosystems Announces Study Results Presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCH® CMMC assay, a Non-Invasive Liquid Biopsy for the Quantification and Molecular Characterization of Circulating Multiple Myeloma Cells
BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 15, 2021 /PRNewswire/ -- Menarini Silicon Biosystems (MSB), a pioneer of liquid biopsy and single cell technologies today announced that Dana-Farber Cancer Institute and the Multiple Myeloma Research Foundation presented data in an oral presentation...
2021-12-15 02:01
2434
CellCarta acquires Biogazelle to strengthen its genomic capabilities and expand into digital PCR (dPCR) services
This acquisition solidifies CellCarta's leadership position in genomic services with a unique combination of assay development and global clinical trial sample analysis capabilities covering a comprehensive range of established and cutting-edge genomic technologies. MONTREAL, Dec. 14, 2021 /PRNe...
2021-12-14 20:25
5128
Clarivate, the Chinese Academy of Engineering and the Higher Education Press of China Release Annual Joint Report to Identify 186 Engineering Fronts
LONDON, Dec. 14, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, theChinese Academy of Engineering (CAE), and the Higher Education Press of China today released their fifth annual collaborative re...
2021-12-14 19:46
3569
Antengene Presents Results of Phase 1b TOUCH Trial of Selinexor for the Treatment of T and NK-Cell Lymphoma at the 2021 American Society of Hematology (ASH) Annual Meeting
SHANGHAI and HONG KONG, Dec. 14, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and onco...
2021-12-14 18:00
4206
Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol
Companies will collaborate on manufacturing and research and development for future indications, and will commercialize Gadopiclenol independently under separate brands Gadopiclenol is a next-generation, macrocyclic contrast agent with high-relaxivity, intended to improve lesion detection and vi...
2021-12-14 14:00
3474
Regional tuberculosis forum shines spotlight on innovation and collaboration driving progress toward ending tuberculosis in Asia Pacific
SINGAPORE, Dec. 14, 2021 /PRNewswire/ -- Over two days on 30 November and 7 December, Johnson & Johnson, together with the National Tuberculosis Programs of Indonesia, the Philippines, Thailand, and Vietnam, hosted the Asia-Pacific Tuberculosis Forum 2021. The forum was convened with the goal of a...
2021-12-14 10:00
3676
Laser Clinics Group launches brand new concept clinic in Singapore as part of Asia expansion
SINGAPORE, Dec. 14, 2021 /PRNewswire/ -- Laser Clinics, the world's leading provider of advanced aesthetic treatments backed by global investment firm KKR, announces the launch of Laser Clinics Asia, a brand-new aesthetic clinic combined with an immersive retail experience. Spanning almost 1500-s...
2021-12-14 10:00
5824
Cargene Closes a US$19.2M Pre-A Round Led by BioTrack Capital
SINGAPORE and SHANGHAI and BOSTON, Dec. 14, 2021 /PRNewswire/ -- Cargene
Biopharma Inc.
2021-12-14 09:00
5289
Innovent Announces Pivotal Phase 2 Results for Parsaclisib (PI3Kδ inhibitor) Presented at ASH 2021 Show Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma
SAN FRANCISCO and SUZHOU, China, Dec. 14, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
2021-12-14 08:00
3996
New App Strengthens Human Connection
PARIS, Dec. 14, 2021 /PRNewswire/ -- Heallo, a new smartphone application
focused on strengthening personal human connections, launchesTuesday, December
14.
Named to combine healing with saying "hello," Heallo
2021-12-14 07:00
2861
New NCCN Guidelines help Patients Better Understand and Participate in the Care of their Cervical Cancer
The free resource, available at NCCN.org/patientguidelines, helps patients know what to expect and participate actively in decisions about their care. PLYMOUTH MEETING, Pa., Dec. 14, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) has published new NCCN Guidelines for Pat...
2021-12-14 04:44
2559
The New Era Biotechnology deepens cooperation between China and Belarus in the Great Stone China Belarus Industrial Park (CBIP)
MINSK, Belarus, Dec. 13, 2021 /PRNewswire/ -- As an enterprise in CBIP, the New Era Biotechnology Co., Ltd. participated in the fourth edition of the China International Import Expo (CIIE) which opened inShanghai on November 5, 2021. Located in Minsk, capital of the Republic of Belarus and a m...
2021-12-13 22:16
2849
Sofwave™ Awarded Elle Magazine's 2021 Future of Beauty Awards!
"The Future is SUPERB™" TUSTIN, Calif., Dec. 13, 2021 /PRNewswire/ -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, has been honored with the Elle Magazine's "2021 Future of Beauty Awards" and named Sofw...
2021-12-13 21:47
3016
Cleverin, Top Made-in-Japan Airborne Disinfectant Brand by Taiko Pharmaceutical, Accelerating Its Business Expansion in Mexico through Acquisition of Its Mexican Distributor
OSAKA, Japan, Dec. 13, 2021 /PRNewswire/ -- Taiko Pharmaceutical Co., Ltd. (hereinafter Taiko), based inOsaka, Japan, has announced that it fully acquired Mexican distributor Torishi S.A. de C.V. inNovember 2021 in order to expand the infection control business. Taiko has worked with the excellen...
2021-12-13 14:00
3644
Physicians At St. David's Medical Center Among First In Nation To Implant Neurostimulator Technology For Advanced Heart Failure
AUSTIN, Texas, Dec. 13, 2021 /PRNewswire/ -- Doctors at St. David's Medical Center recently became among the first in the U.S. to implant a new neurostimulator technology to help treat advanced heart failure. The Barostim System is the only technology approved by the Food and Drug Administration ...
2021-12-13 10:08
3718
Phase 3 Data Demonstrate TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine Significantly Improves Event-Free Survival and Overall Survival in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia
TIBSOVO in combination with azacitidine compared to placebo plus azacitidine also demonstrated significant improvements in complete remission rate, complete remission and complete remission with partial hematologic recovery rate and objective response rate Safety profile was favorable and consis...
2021-12-13 09:03
3779
Antengene Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate ATG-017 in Combination with Opdivo® (nivolumab) in Advanced Solid Tumors
* ATG-017 is an oral small molecule ERK1/2 inhibitor; Opdivo® is aPD-1 checkpoint inhibitor * Combination study to begin in H12022 SHANGHAI and HONG KONG, Dec. 13, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical co...
2021-12-13 08:30
4209
Innovent and IASO Announced Updated Clinical Data of BCMA CAR-T Therapy in Oral Presentation at 2021 ASH Annual Meeting
SAN FRANCISCO, U.S. and SUZHOU, China, Dec. 13, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other ma...
2021-12-13 08:00
4526
Brii Bio Announces Amubarvimab/Romlusevimab Combination Retains Neutralizing Activity Against Omicron SARS-CoV-2 Variant
DURHAM, N.C. and BEIJING, Dec. 12, 2021 /PRNewswire/ -- Brii Biosciences
2021-12-12 18:50
5315
Phase 3 Data Show That TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine Significantly Improves Event-Free Survival and Overall Survival in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia
* TIBSOVO in combination with azacitidine compared to placebo plus azacitidine also demonstrated significant improvement in complete remission rate, complete remission and complete remission with partial hematologic recovery rate and objective response rate * Safety profile was favorable and ...
2021-12-12 09:00
6994
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 292 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 281 media titles]
2026-10-15 10:00Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 279 media titles]
2026-10-15 12:59
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 275 media titles]
2026-10-09 13:21Most Read
Amap and Sands China mark the delivery of the first Tutu robots, with expected indoor navigation and 3D resort previews
2026-10-10 16:43
15970
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
14830